πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 5 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11931402

Compositions for treating heart disease by inhibiting the action of mAKAP-Ξ²

Anchored RSK3 Inhibitors, LLC Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11229679

Compositions for treating heart disease by inhibiting the action of mAKAPΞ²

Anchored RSK3 Inhibitors, LLC Β· Granted Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10617737

Compositions for treating heart disease by inhibiting the action of mAKAP-Ξ²

Anchored RSK3 Inhibitors, LLC Β· Granted Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937228

Treatment of myocardial infarction by inhibiting the action of mAKAPΞ²

Anchored RSK3 Inhibitors, LLC Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9132174

Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)

Anchored RSK3 Inhibitors, LLC Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted